-
-
公开(公告)号:KR800001381B1
公开(公告)日:1980-11-26
申请号:KR800003162
申请日:1980-08-09
Applicant: HOFFMANN LA ROCHE
IPC: C07J63/00
-
公开(公告)号:KR800000176B1
公开(公告)日:1980-03-10
申请号:KR760000811
申请日:1976-04-02
Applicant: HOFFMANN LA ROCHE
IPC: C07J63/00
Abstract: D-homosteroid derivs. (I; R6 = H,F, Cl or methyl group, R9 = H,F, Cl or Br, R11 = iodo, (α-H, β-fluoro) or (α-H, β-chloro), R17a = hydroxy or acyloxy group, R20 = lower alkyl, halo-(lower alkyl), hydroxy-(lower alkyl), acyloxy-(lower alkyl) or (lower alkoxycarbonyl-(lower alkyl) group, R20I = H, lower alkyl, halo-(lower alkyl), hydroxy-(lower alkyl), acyloxy-(lower alkyl) or (lower alkoxycarbonyl) - (lower alkyl) group), useful as antiinflammatory agent, were prepd. by substituting functional group (COOR20I) of D-homosteroid(II).
-
-
-
公开(公告)号:DK144947B
公开(公告)日:1982-07-12
申请号:DK32077
申请日:1977-01-26
Applicant: HOFFMANN LA ROCHE
Inventor: ALIG L , FUERST A , MUELLER M , KERB U , WIECHERT R
IPC: C07J20060101 , C07J63/00
-
公开(公告)号:DK143758C
公开(公告)日:1982-03-29
申请号:DK123075
申请日:1975-03-24
Applicant: HOFFMANN LA ROCHE
Inventor: ALIG L , FUERST A , MUELLER M , KERB U , WIECHERT R
IPC: C07J63/00 , A61K31/56 , A61K31/57 , C07J20060101
-
公开(公告)号:ZA80888B
公开(公告)日:1981-02-25
申请号:ZA80888
申请日:1980-02-15
Applicant: HOFFMANN LA ROCHE
IPC: C07C43/196 , A61K31/045 , A61K31/10 , A61K31/12 , A61K31/19 , A61K31/265 , A61K31/275 , A61K31/34 , A61K31/585 , A61P5/38 , C07C27/00 , C07C29/147 , C07C35/37 , C07C41/00 , C07C43/18 , C07C45/00 , C07C49/727 , C07C51/00 , C07C59/42 , C07C59/62 , C07C59/90 , C07C67/00 , C07C253/00 , C07C255/46 , C07C313/00 , C07C323/17 , C07C323/22 , C07C323/61 , C07C325/00 , C07C327/28 , C07D307/94 , C07J20060101 , C07J19/00 , C07J
-
公开(公告)号:NZ186988A
公开(公告)日:1980-05-27
申请号:NZ18698878
申请日:1978-04-17
Applicant: HOFFMANN LA ROCHE
Inventor: KEB U , MUELLER M , ALIG L , WIECHART R , FUERST A
Abstract: D-homopregnanes of the formula I wherein R6 is hydrogen, chloro, fluoro or methyl; X is beta -hydroxymethylene or carbonyl; R17a is hydroxy, lower alkanoyloxy or aroyloxy; R21 is hydrogen, chloro, fluoro, hydroxy, lower alkanoyloxy, aroyloxy, sulfate or phosphate; and the dotted line in the 1,2-position of the A-ring denotes an additional carbon-carbon bond AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS THE ACTIVE INGREDIENT ARE DISCLOSED. The D-homopregnanes of the present invention exhibit hormonal activity and are useful for the treatment of inflammation.
-
公开(公告)号:DK195979A
公开(公告)日:1979-11-13
申请号:DK195979
申请日:1979-05-10
Applicant: HOFFMANN LA ROCHE
Inventor: ALIG L , FUERST A , MUELLER M , KERB U , WIECHERT R
IPC: A61K31/235 , C07J63/00 , C07J
Abstract: The present disclosure is concerned with 17a-(m-iodobenzoyloxy) substituted D-homosteroids and a process for their manufacture. The compounds are useful as intermediates and also as hormonal agents, particularly progestational agents.
-
-
-
-
-
-
-
-
-